Covered recipient · General Payments record
CHARLENE CRUZ-ROBERTSON
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021
$630.76
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $630.76 | 19 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $362.91 | 6 |
| Lilly USA, LLC | $197.66 | 9 |
| Amgen Inc. | $70.19 | 4 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $630.76 | 19 |
Payment records · PY2021 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.99 | 03/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825956723 | CMS |
| Amgen Inc. | $16.78 | 03/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 826473747 | CMS |
| Amgen Inc. | $18.48 | 05/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 826473745 | CMS |
| Amgen Inc. | $18.94 | 05/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825956727 | CMS |
| Lilly USA, LLC | $21.77 | 01/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818774437 | CMS |
| Lilly USA, LLC | $16.98 | 01/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818810093 | CMS |
| Lilly USA, LLC | $18.70 | 03/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818810095 | CMS |
| Lilly USA, LLC | $24.19 | 03/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818849081 | CMS |
| Lilly USA, LLC | $25.59 | 04/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818847653 | CMS |
| Lilly USA, LLC | $22.69 | 04/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818774439 | CMS |
| Lilly USA, LLC | $21.36 | 04/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818851281 | CMS |
| Lilly USA, LLC | $21.88 | 04/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818774441 | CMS |
| Lilly USA, LLC | $24.50 | 04/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818841541 | CMS |
| Novo Nordisk Inc | $21.80 | 04/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811398845 | CMS |
| Novo Nordisk Inc | $19.38 | 04/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811398851 | CMS |
| Novo Nordisk Inc | $94.18 | 05/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811005302 | CMS |
| Novo Nordisk Inc | $96.85 | 06/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811626923 | CMS |
| Novo Nordisk Inc | $112.97 | 06/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811284131 | CMS |
| Novo Nordisk Inc | $17.73 | 06/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811626927 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.